Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-20 4:21 pm Sale |
2023-11-16 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 95,332 18.100% |
-67,000 (-41.27%) |
Filing History |
| 2023-11-17 08:27 am Unchanged |
2023-11-17 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 7,559,729 16.000% |
0 (Unchanged) |
Filing History |
| 2023-11-14 4:57 pm Unchanged |
2023-11-13 | 13D | Kinnate Biopharma Inc. KNTE |
ORBIMED ADVISORS LLC | 7,559,729 16.000% |
0 (Unchanged) |
Filing History |
| 2023-11-13 08:51 am Purchase |
2023-11-09 | 13D | Alpine Immune Sciences, Inc. ALPN |
ORBIMED ADVISORS LLC | 4,226,843 7.300% |
145,251 (+3.56%) |
Filing History |
| 2023-11-01 5:08 pm Sale |
2023-10-30 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 162,332 18.100% |
-18,105 (-10.03%) |
Filing History |
| 2023-10-04 4:27 pm Purchase |
2023-10-03 | 13D | Synlogic, Inc. SYBX |
ORBIMED ADVISORS LLC | 401,998 4.700% |
401,998 (New Position) |
Filing History |
| 2023-10-02 4:41 pm Purchase |
2023-09-29 | 13D | Apollomics, Inc. APLM |
ORBIMED ADVISORS LLC | 180,436 20.200% |
173,811 (+2623.32%) |
Filing History |
| 2023-09-21 4:52 pm Sale |
2023-08-04 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 2,189,111 5.200% |
-153,121 (-6.54%) |
Filing History |
| 2023-09-18 4:19 pm Sale |
2023-09-12 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 29,982 2.800% |
-16,005 (-34.80%) |
Filing History |
| 2023-09-14 4:21 pm Purchase |
2023-08-04 | 13D | Ikena Oncology, Inc. IKNA |
ORBIMED ADVISORS LLC | 2,342,232 5.500% |
405,346 (+20.93%) |
Filing History |
| 2023-09-05 4:20 pm Sale |
2023-08-30 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 45,988 4.200% |
-18,315 (-28.48%) |
Filing History |
| 2023-08-23 4:56 pm Sale |
2023-08-09 | 13D | PMV Pharmaceuticals, Inc. PMVP |
ORBIMED ADVISORS LLC | 6,563,077 13.500% |
-26,253 (-0.40%) |
Filing History |
| 2023-08-17 4:30 pm Sale |
2023-08-15 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 64,303 5.900% |
-25,354 (-28.28%) |
Filing History |
| 2023-08-11 4:23 pm Purchase |
2023-08-10 | 13D | Gracell Biotechnologies Inc. GRCL |
ORBIMED ADVISORS LLC | 7,641,531 8.000% |
57,955 (+0.76%) |
Filing History |
| 2023-08-03 4:59 pm Unchanged |
2023-08-01 | 13D | Xtant Medical Holdings, Inc. XTNT |
ORBIMED ADVISORS LLC | 73,114,592 56.700% |
0 (Unchanged) |
Filing History |
| 2023-08-02 5:02 pm Sale |
2023-07-31 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 89,658 8.300% |
-8,568 (-8.72%) |
Filing History |
| 2023-07-24 4:33 pm Purchase |
2023-07-20 | 13D | Turnstone Biologics Corp. TSBX |
ORBIMED ADVISORS LLC | 3,099,265 13.400% |
3,099,265 (New Position) |
Filing History |
| 2023-07-19 4:12 pm Purchase |
2023-07-17 | 13D | Theseus Pharmaceuticals, Inc. THRX |
ORBIMED ADVISORS LLC | 17,713,600 40.700% |
479,932 (+2.78%) |
Filing History |
| 2023-07-17 4:11 pm Sale |
2023-07-13 | 13D | Galecto, Inc. GLTO |
ORBIMED ADVISORS LLC | 98,226 9.600% |
-9,641 (-8.94%) |
Filing History |
| 2023-06-29 4:36 pm Purchase |
2023-06-27 | 13D | Passage Bio, Inc. PASG |
ORBIMED ADVISORS LLC | 8,034,000 14.700% |
1,192,577 (+17.43%) |
Filing History |